PEAK6 Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,478
Closed -$271K 4443
2023
Q3
$261K Buy
3,478
+2,468
+244% +$190K ﹤0.01% 2885
2023
Q2
$77.8K Buy
+1,010
New +$80.6K ﹤0.01% 3318
2023
Q1
Sell
-2,453
Closed -$203K 4537
2022
Q4
$211K Buy
+2,453
New +$194K ﹤0.01% 3248
2022
Q3
Sell
-10,867
Closed -$685K 5368
2022
Q2
$687K Sell
10,867
-103,620
-91% -$6.42M ﹤0.01% 3475
2022
Q1
$6.81M Buy
114,487
+86,135
+304% +$5.51M 0.01% 897
2021
Q4
$2.06M Sell
28,352
-125,150
-82% -$8.62M ﹤0.01% 1860
2021
Q3
$10.7M Buy
153,502
+81,693
+114% +$5.74M 0.02% 665
2021
Q2
$4.94M Sell
71,809
-42,669
-37% -$2.85M 0.01% 1114
2021
Q1
$7.4M Sell
114,478
-76,917
-40% -$4.96M 0.02% 790
2020
Q4
$11.2M Sell
191,395
-89,019
-32% -$5.37M 0.02% 625
2020
Q3
$17.7M Buy
280,414
+202,705
+261% +$14.1M 0.04% 375
2020
Q2
$5.98M Sell
77,709
-126,504
-62% -$9.69M 0.02% 718
2020
Q1
$15.3M Sell
204,213
-12,130
-6% -$838K 0.09% 217
2019
Q4
$14.1M Buy
216,343
+142,740
+194% +$9.3M 0.07% 282
2019
Q3
$4.67M Sell
73,603
-25,481
-26% -$1.67M 0.03% 713
2019
Q2
$6.69M Sell
99,084
-74,647
-43% -$4.91M 0.04% 534
2019
Q1
$11.3M Sell
173,731
-126,753
-42% -$8.42M 0.07% 323
2018
Q4
$18.8M Buy
300,484
+107,286
+56% +$7.5M 0.12% 161
2018
Q3
$14.9M Buy
+193,198
New +$14.6M 0.07% 319

Other funds holding GILD

PEAK6 Investments's GILD Position: Q4 2023 in Review

PEAK6 Investments sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 3,478 shares — an estimated $271K sold.

PEAK6 Investments first reported a position in GILD in Q3 2018 and held it in 19 quarters. The position peaked at $18.8M in Q4 2018. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • PEAK6 Investments reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 3,478 Gilead Sciences shares in Q4 2023, an estimated $271K.
  • PEAK6 Investments first reported a position in Gilead Sciences in Q3 2018 and held it in 19 quarters.
  • PEAK6 Investments's Gilead Sciences position peaked at $18.8M in Q4 2018.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.